A Japanese pharmaceutical startup is working on a drug that could make dentures and implants obsolete. The drug, which is still in the early stages of development, aims to stimulate the growth of new teeth in humans.
The startup, called Toregem Biopharma, was founded in 2021 by Dr. Katsu Takahashi, a former researcher at RIKEN, Japan’s largest research institute. Dr. Takahashi and his team discovered a way to activate the tooth buds, which are dormant cells that have the potential to become teeth, but usually disappear during embryonic development.
The drug inhibits a protein called USAG-1, which suppresses the development of tooth buds. By blocking this protein, the drug allows the tooth buds to grow into new teeth. The drug is administered by injection into the gums.
“We hope our drug will be a game-changer for millions of people who suffer from tooth loss and dental problems,” Dr. Takahashi said in an interview. “Our goal is to restore the natural function and appearance of teeth, and improve the quality of life of our patients.”
The drug could benefit patients with congenital tooth loss, a rare condition that affects about one in 2,000 people, as well as adults who have lost teeth due to cavities, gum disease, trauma or aging.
According to Dr. Takahashi, the drug has been tested on mice and monkeys, and has shown promising results. The company plans to conduct clinical trials on healthy adults in July 2024, and aims to put the drug on the market by 2030.
The drug has attracted attention from experts around the world, who have praised its innovation and potential.
“This is a revolutionary discovery that could transform dentistry as we know it,” said Dr. Paul Sharpe, a professor of craniofacial biology at King’s College London, who is not involved in the project. “The ability to grow new teeth in humans is a dream come true for many dentists and patients alike.”
Dr. Hiroshi Matsui, a dentist and a researcher at Tokyo University, who has collaborated with Toregem Biopharma, said he was excited about the prospect of using the drug in his practice.
“I have seen many patients who are unhappy with their dentures or implants, or who cannot afford them,” he said. “This drug could offer them a more natural and affordable alternative.”
Dr. Masato Saito, a professor of oral and maxillofacial surgery at Osaka University, who has also worked with Toregem Biopharma, said he was impressed by the scientific rigor and ethical standards of the company.
“They have done extensive research and experiments to ensure the safety and efficacy of their drug,” he said. “They have also obtained approval from the relevant authorities and followed the ethical guidelines for animal and human studies.”
Dr. Ritsuko Morita, a senior scientist at RIKEN Center for Biosystems Dynamics Research, who was Dr. Takahashi’s mentor, said she was proud of his achievement and its social impact.
“This is a great example of how basic research can lead to novel applications that benefit society,” she said. “I am very happy for Dr. Takahashi and his team, and I hope their drug will succeed in helping people who need it.”
Relevant articles:
– Japan pharma startup developing world-first drug to grow new teeth, Emirates 24/7, September 25, 2023
– Japanese scientists developing drug to grow new teeth in humans, ABC News, September 25, 2023
– This Japanese Company Is Working On World’s First Drug To Grow New Teeth, NDTV, September 25, 2023
– New Drug Being Developed to Stimulate Growth of New Teeth, Clinical Trials to Begin in 2024, Clayton County Register, September 25, 2023